anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Resolution

Beat collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 42,534
Current window 24,871-24,900
Pages 1,418
Rows per page 30
Beat: Resolutionclear collectionreset all
18 30 60

Beat

24,871-24,900 of 42,534

filter-aware
51
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
52
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
53
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
54
The slide highlights a 7% decline in combined WELLBUTRIN/APLENZIN revenue.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
55
Includes footnotes regarding non-GAAP information and constant currency calculations.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
56
Includes footnotes regarding non-GAAP information and constant currency calculations.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
57
The table tracks revenue in millions of dollars for 10 products across 5 quarters (3Q20 to 3Q21).Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
58
The table tracks revenue in millions for 10 product lines across 5 quarters (3Q20 to 3Q21).Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
59
The table lists 10 products with their respective quarterly revenues in millions of dollars.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
60
Data represents international sales only.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
61
Data represents U.S. only sales.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
62
The table lists products by rank and their respective quarterly revenues in millions of dollars.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
63
The table reconciles GAAP net income to non-GAAP adjusted net income, detailing specific adjustments like amortization, impairments, and restructuring costs.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
64
Includes footnotes regarding non-GAAP adjustments and corporate allocation exclusions.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
65
The slide provides supplemental financial metrics for Bausch + Lomb, likely for valuation or segment analysis purposes.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
66
The slide contains two distinct tables: one for Revenue and one for EBITA (non-GAAP).Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
67
The table provides supplemental financial metrics for Bausch Pharma, likely for valuation or modeling purposes.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
68
Includes footnotes regarding non-GAAP adjustments and fiscal year reporting.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
69
The table provides a detailed breakdown of financial metrics for the International Rx segment, including non-GAAP EBITA.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
70
The table breaks down revenue into Ortho Dermatologics and Global Solta components.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
71
The table provides a detailed breakdown of financial metrics for the Diversified Products segment, including specific revenue streams (Neuro & Other, Generics, Dentistry).Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
72
The slide provides a detailed breakdown of non-GAAP adjustments including amortization, asset impairments, restructuring, and other one-time costs.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
73
The slide provides a detailed breakdown of non-GAAP adjustments including amortization, impairments, and restructuring costs.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
74
Contains footnotes 1-5 explaining segment reporting and asset impairment details.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
75
The table reconciles GAAP operating income to non-GAAP by adding back acquisition-related costs and adjustments.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
76
The table provides a detailed breakdown of non-GAAP adjustments including asset impairments, restructuring costs, and litigation expenses.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
77
The table provides a clear breakdown of adjustments including taxes, D&A, asset impairments, acquisition costs, and share-based compensation.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
78
Includes adjustments for foreign exchange rates, divestitures, and discontinuations.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
79
The table breaks down revenue adjustments by segment, including foreign exchange impacts and divestitures/discontinuations.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
80
The table is split into two main sections: calculation of organic revenue for current periods and calculation of organic revenue for prior periods, followed by a growth comparison.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit